Research & Development
Italian drug regulator endorses Moderna COVID-19 vaccine for adolescents
28 July 2021 -

AIFA, the drug regulator in Italy, has approved the use of Moderna's (Nasdaq:MRNA) COVID-19 vaccine for children 12-17 years old, Reuters news agency reported on Wednesday.

This is the second vaccine endorsed for adolescents in Italy, alongside that of Pfizer.

The Italian drug regulator stated that it had endorsed the vaccine Spikevax for teens, fully accepting the recommendation made by the European Medicines Agency (EMA) on 23 July 2021,

AIFA added that "The available data demonstrate the efficacy and safety of the vaccine also for subjects in this age group."



Related Headlines